Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Nina Kim, Joaquin Estrada, Isabella Chow, Aleksandrina Ruseva, Abhilasha Ramasamy, Chakkarin Burudpakdee & Christopher M Blanchette. (2023) The Relative Value of Anti-Obesity Medications Compared to Similar Therapies. ClinicoEconomics and Outcomes Research 15, pages 51-62.
Read now
Read now
Santosh Bhusal, Sherilyn Diomampo & Marina N Magrey. (2016) Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia. Drug, Healthcare and Patient Safety 8, pages 13-23.
Read now
Read now
Articles from other publishers (11)
Joshua A. Lile, William W. Stoops & Michael J. Wesley. 2023. Cannabis Use, Neurobiology, Psychology, and Treatment. Cannabis Use, Neurobiology, Psychology, and Treatment
605
620
.
Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022)
CDC Clinical Practice Guideline for Prescribing Opioids for Pain
—
United States, 2022
. MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Crossref
Insa Backhaus, Alice Mannocci & Giuseppe La Torre. (2019) A Systematic Review of Economic Evaluation Studies of Drug-Based Non-Malignant Chronic Pain Treatment. Current Pharmaceutical Biotechnology 20:11, pages 910-919.
Crossref
Crossref
Adrián Pérez-Aranda, Francesco D’Amico, Albert Feliu-Soler, Lance M. McCracken, María T. Peñarrubia-María, Laura Andrés-Rodríguez, Natalia Angarita-Osorio, Martin Knapp, Javier García-Campayo & Juan V. Luciano. (2019) Cost–Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study). Journal of Clinical Medicine 8:7, pages 1068.
Crossref
Crossref
Margreet S. H. Wortman, Joran Lokkerbol, Johannes C. van der Wouden, Bart Visser, Henriëtte E. van der Horst & Tim C. olde Hartman. (2018) Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review. PLOS ONE 13:10, pages e0205278.
Crossref
Crossref
Milena De Felice & Michael H Ossipov. (2016) Cortical and subcortical modulation of pain. Pain Management 6:2, pages 111-120.
Crossref
Crossref
Lindsay Parker, Rachel Huelin, Zarmina Khankhel, Radek Wasiak & Joaquin Mould. (2015) A Systematic Review of Pharmacoeconomic Studies for Pregabalin. Pain Practice 15:1, pages 82-94.
Crossref
Crossref
Juan V Luciano, Francesco D’Amico, Marta Cerdà-Lafont, María T Peñarrubia-María, Martin Knapp, Antonio I Cuesta-Vargas, Antoni Serrano-Blanco & Javier García-Campayo. (2014) Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial. Arthritis Research & Therapy 16:5.
Crossref
Crossref
Tracy L. Skaer. (2014) Fibromyalgia: Disease Synopsis, Medication Cost Effectiveness and Economic Burden. PharmacoEconomics 32:5, pages 457-466.
Crossref
Crossref
Ankesh Kukkar, Anjana Bali, Nirmal Singh & Amteshwar Singh Jaggi. (2013) Implications and mechanism of action of gabapentin in neuropathic pain. Archives of Pharmacal Research 36:3, pages 237-251.
Crossref
Crossref
Michael H. Ossipov. (2012) The Perception and Endogenous Modulation of Pain. Scientifica 2012, pages 1-25.
Crossref
Crossref